New Therapeutic Strategies to Combat Antibacterial Resistance


New York Academy of Sciences NYAS organized a symposium and poster presentation session titled New Therapeutic Strategies to Combat Antibacterial Resistance. There were three sessions in which implications of antimicrobial resistance, advent of new therapeutic era and host-pathogen interaction were discussed. Following sessions were covered during the symposium:

Session 1: Leveraging Existing Therapies against New Targets

Session 2: Innovative Approaches to Develop Novel Therapies

Session 3: Exploiting Host-Pathogen Interactions to Develop New Therapeutics

The Symposium provided Faria Khan with the scientific insight into the global problem of pathogen induced drug resistance, the possible factors behind it and methodologies to determine the biological pathway which induces the resistance. One of the factors could be environmental aerosols induced resistance and pathogen entry into host cells and current research by research groups at Harvard University, Yale and Nottingham provided Faria with the scientific knowledge relevant for her MSCA funded research. Faria Khan also presented a  poster at the conference titled “Stability Testing of Antimicrobial Heliotropium Crispum Silver- Nanoparticles as a Commercial Formulation for treatment against Drug Resistant Bacterial Pathogens.”


20-25 Oct., 2018


New York, United States


New York Academy of Sciences


Faria Khan

More information about the event .

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 711859.